Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment
- PMID: 36212483
- PMCID: PMC9540406
- DOI: 10.3389/fonc.2022.949332
Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment
Abstract
Traditional Chinese medicine (TCM), including herbal medicine, acupuncture and meditation, has a wide range of applications in China. In recent years, herbal compounding and active ingredients have been used to control tumor growth, reduce suffering, improve quality of life, and prolong the life span of cancer patients. To reduce side effects, herbal medicine can be used in conjunction with radiotherapy and chemotherapy or can be used as an adjuvant to strengthen the immune effect of anticancer vaccines. In particular, in the immunosuppressed tumor microenvironment, herbal medicine can have antitumor effects by stimulating the immune response. This paper reviews the advances in research on antitumor immunomodulation in Chinese herbal medicine, including the regulation of the innate immune system, which includes macrophages, MDSCs, and natural killer cells, and the adaptive immune system, which includes CD4+ T cells, CD8+ T cells, and regulatory T cells (Tregs), to influence tumor-associated inflammation. In addition, a combination of active ingredients of herbal medicine and modern nanotechnology alter the tumor immune microenvironment. In recent years, immunological antitumor therapy in TCM has been applied on a reasonably large scale both nationally and internationally, and there is potential for further clinical expansion. Investigation of immune modulation mechanisms in Chinese herbal medicine will provide novel perspectives of how herbal medicine controls tumor growth and metastasis, which will contribute to the evolution of tumor research.
Methodology: Experimental research between the years of 2012-2022, meta-analysis and reviews for the period 2002-2022 found on the Databases including PubMed, Embase, and the Cochrane database were used. The inclusion criteria were experimental research literature addressing the anti-tumor immunological effects of active ingredients and nanoparticles in Chinese herbal medicine. Exclusion criteria were articles that addressed Chinese herbal medicine and nano-formulations without discussing anti-tumor immunological effects in innate, adaptive immune cells, MDSCs, and nuclear factors.
Keywords: TCM; nano-formulation; oncology; traditional Chinese medicine; tumor immune microenvironment.
Copyright © 2022 Sun, Wu, Wang and Deng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Antitumor effects of immunity-enhancing traditional Chinese medicine.Biomed Pharmacother. 2020 Jan;121:109570. doi: 10.1016/j.biopha.2019.109570. Epub 2019 Nov 9. Biomed Pharmacother. 2020. PMID: 31710893 Review.
-
Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.Front Immunol. 2021 Jan 21;11:609705. doi: 10.3389/fimmu.2020.609705. eCollection 2020. Front Immunol. 2021. PMID: 33552068 Free PMC article. Review.
-
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28. J Ethnopharmacol. 2020. PMID: 31891799 Review.
-
Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment.Front Oncol. 2021 Oct 14;11:746917. doi: 10.3389/fonc.2021.746917. eCollection 2021. Front Oncol. 2021. PMID: 34722304 Free PMC article. Review.
-
Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine.Molecules. 2024 May 17;29(10):2374. doi: 10.3390/molecules29102374. Molecules. 2024. PMID: 38792234 Free PMC article. Review.
Cited by
-
Belamcanda chinensis extract inhibits non-small cell lung cancer proliferation and induces apoptosis via inhibiting the MAPK (Ras/Raf) and Akt pathways.Heliyon. 2024 Aug 9;10(16):e36032. doi: 10.1016/j.heliyon.2024.e36032. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39229537 Free PMC article.
-
Aloe-emodin alleviates inflammatory bowel disease in mice by modulating intestinal microbiome homeostasis via the IL-4/IL-13 axis.Heliyon. 2024 Jul 22;10(15):e34932. doi: 10.1016/j.heliyon.2024.e34932. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39157379 Free PMC article.
-
Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy.Pharmaceuticals (Basel). 2024 May 15;17(5):636. doi: 10.3390/ph17050636. Pharmaceuticals (Basel). 2024. PMID: 38794206 Free PMC article. Review.
-
Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer.Cancer Biol Med. 2024 Feb 5;20(12):1021-34. doi: 10.20892/j.issn.2095-3941.2023.0222. Cancer Biol Med. 2024. PMID: 38318840 Free PMC article. Review.
-
Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis.Heliyon. 2024 Jan 9;10(2):e24395. doi: 10.1016/j.heliyon.2024.e24395. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38268819 Free PMC article. Review.
References
-
- Huang S, Peng W, Mao D, Zhang S, Xu P, Yi P, et al. . Kangai injection, a traditional Chinese medicine, improves efficacy and reduces toxicity of chemotherapy in advanced colorectal cancer patients: A systematic review and meta-analysis. Evid Based Complement Alternat Med (2019):8423037. doi: 10.1155/2019/8423037 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials